🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are pleased to announce that Oliver Eng, MD, has been selected to serve as new Associate Editor for the Gastrointestinal Surgery section of JSR. Dr. Eng is an Associate Professor of Clinical Surgery in the Division of Surgical Oncology UC Irvine Surgery.

Enjoyed celebrating our wonderful Emory General Surgery Chief Residents graduate last night with my friend and mentor @aa_chahine Congrats to all!! Emory Surgery Edward Lin Maria Russell Elissa A Falconer Jyotirmay Sharma

Best job in the 🌎🌍🌏….being a dad to these great kids. Happy #FathersDay2024 to all the dads out there. Hug them twice as hard today! #BlessedAndGrateful

.⁦Emory School of Medicine⁩ ⁦Winship Cancer Institute of Emory University⁩ ⁦GradyHealth⁩ ⁦Maria Russell⁩ Marti Russell debating Dr. Jordan Berlin pros and cons of neoadjuvant therapy for pancreas cancer making us proud!! #DDHO2024

SSO announces publication of its 1st consensus statement, Assessing the Evidence For and Utility of Gene Expression Profiling of Primary Cutaneous Melanoma. Developed by melanoma specialists around four clinical questions on GEP testing for primary CM. ow.ly/OSAa50TWrhM

Flying home to #ATL from “the City” that still holds a special place in my heart. #NYC (and always will)

The latest SSO consensus statement urges caution with gene expression profiling (GEP) for primary cutaneous melanoma. Given evolving evidence, GEP is recommended as an investigational tool in research or clinical trials. Read more: Annals of Surgical Oncology: surgonc.org/annals-of-surg…

I get asked how GEP tests should be used in cutaneous melanoma at every meeting. Great to see this consensus statement out in print. Society of Surgical Oncology

.⁦Emory School of Medicine⁩ ⁦Emory SOM at Grady Hospital⁩ ⁦Maria Russell⁩ ⁦granny surgeon number 1⁩ ⁦Emory Surgery⁩ This year’s SURG-20 class. Notice something special? Yep! All women. Truly an honor to teach these amazing future doctors ⁦WISER Podcast⁩

Join us on April 22, 2025, for the Emory at Grady Faculty Awards. This ceremony will recognize outstanding faculty contributions and achievements. Hope to see you there!279

April Issue: Risk-Prediction Models for Clinical Decision-Making in #Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians Leti van Bodegom-Vos rdcu.be/ehSLh Dorian Y. García-Ortega MD, MSc,PhD, FACS Syed A. Ahmad

Thank you for your excellent talks and for sharing your experiences with our residents in rocking chair rounds!

May Issue: Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with #Melanoma . Roger Olofsson Bagge Cristina O’Donoghue J. Harrison Howard, MD MarkFariesMD Jonathan Zager, MD rdcu.be/ekVZg Dorian Y. García-Ortega MD, MSc,PhD, FACS Syed A. Ahmad

#AudioVisualAbstract : Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive #BreastCancer : A Retrospective Analysis rdcu.be/ek3b4 Belén Merck 👩‍⚕️🧑🏻‍🎓🩺🔬📚 Syed A. Ahmad

May Issue: Clinical Significance of Coiled-Coil Domain-Containing Protein 25 Expression in #Esophageal #SquamousCellCarcinoma rdcu.be/ek3eF @lindSLUe Syed A. Ahmad

Featured: Strategies for Recurrent #ColorectalLiver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of #MultidisciplinaryTreatment . Kosuke Kobayashi ow.ly/z35w50VON9C Micah J. Brainerd, M.D. Syed A. Ahmad

#AudioVisualAbstract : Endoscopic Evaluation of #PathologicalCompleteResponse Using #DeepNeuralNetwork in #EsophagealCancer Patients Who Received Neoadjuvant Chemotherapy—Multicenter Retrospective Study from Four Japanese Esophageal Centers rdcu.be/elfqy Syed A. Ahmad

#AudioVisualAbstract : Results of a Randomized Clinical Study of #Gemcitabine Plus Nab-Paclitaxel Versus Gemcitabine Plus S-1 as Neoadjuvant Chemotherapy for Resectable and Borderline Resectable #Pancreatic #DuctalAdenocarcinoma rdcu.be/eloqh Syed A. Ahmad

👏👏👏

New weekly Annals of Surgical Oncology featured article: Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.  ow.ly/3Lwi50VCXJG #ASOFeaturedArticle